Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Vittorio Perfetti, Erik Laurini, Suzana Aulić, Maurizio Fermeglia, Roberta Riboni, Marco Lucioni, Elena Dallera, Sara Delfanti, Luigi Pugliese, Francesco Saverio Latteri, Andrea Pietrabissa, Sabrina Pricl
Published Jul 18, 2017 · Vol. 8, No. 34 · pp. 56158-56167
Elena Elimova, Rebecca S. Slack, Hsiang-Chun Chen, Venkatram Planjery, Hironori Shiozaki, Yusuke Shimodaira, Nick Charalampakis, Quan Lin, Kazuto Harada, Roopma Wadhwa, Jeannelyn S. Estrella, Dilsa Mizrak Kaya, Tara Sagebiel, Jeffrey H. Lee, Brian Weston, Manoop Bhutani, Mariela Blum Murphy, Aurelio Matamoros, Bruce Minsky, Prajnan Das, Paul F. Mansfield, Brian D. Badgwell, Jaffer A. Ajani
Published Jul 13, 2017 · Vol. 8, No. 46 · pp. 81430-81440
